Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

JAPFA Ltd.



JAPFA Ltd (or the "Company") is offering 248m shares at $0.80 each for a listing on the Singapore Exchange. The IPO will close on 13 August 2014 at 12pm and starts trading on 15 August. The international offering will be 231.2m shares with the balance 16.8m shares for the public (at least this is a decent amount). There is an option to over-allot 37.2m shares for stabilization and the placement tranche was 5x covered despite the recent weak sentiments.

Principal Business

JAPFA is a leading agri-food company that produces multiple protein foods with operations in 5 high growth emerging Asian markets. The Company has a long history and developed core competencies in animal feed production, animal breeding, livestock fattening and consumer food.


Dairy business


This is quite an informational prospectus, so I decided to cut and paste the pictures above. It has a growing diary business in China and supply to leading producers there such as Yili and Mengniu. 

A quick look at trading comps for some of the dairy companies in China is presented below (source from Capital IQ).


You can see that the trading comps are trading at rich valuation in China for Dairy companies from between 20-40x PE. However, having said that, the overall revenue from China and from Dairy is still low, contributing only 3.5% of the Company's topline. If the Dairy business can continue to increase, the valuation of the Company will likely head north as it will become an interesting acquisition target for the Chinese companies.

Animal Protein Business

The Company is also a producer of high quality animal proteins and premium feed. This is the main business line for the company, contributing to the majority of the revenue. It is a low margin but stable business. I believe the Company is trying to position itself away from business into the higher value add diary and consumer food businesses.


Consumer Food

The Company manufactures frozen food in Indonesia and Vienam under the "So Good", "So Nice"and "So Fresh" brands.


Financial Highlights


Revenue has been increasing steadily over the last 3 years but unfortunately, the profits has fluctuated over the years with Q1 2014 coming in lower as well. Having said that, i am pleased to see an increasing EBITDA line over the last 3 years. 


What i like about the Company
  • One of the largest poultry producer in Indonesia
  • Leading premium milk producer in China
  • Emerging market is the right place to be with rising income and a large population
  • Vertically integrated business model allows the Company to extract profits across the value chain
  • Promising diary business in China and with a leading position in Indonesia 
  • Strong growth strategies in key markets to replicate farms and facilities in Inner Mongolia and China
  • Well diversified agri business
  • The independent directors subscribed for the reserved shares in a meaningful way of between 300,000 to 625,000 shares

My Concerns
  • Live stock business while profitable, is always difficult to handle due to factors such as internal controls. 
  • Biological assets are hard to value and "stock take" and any natural disease or man-caused scandals can wipe the entire live stock or affect the company drastically
  • Still primarily an Indonesia firm with >80% revenue derived from there, implying single country risk as well as exposure to Indonesia currency, which can be very volatile
  • Still primarily a "family-owned" by Santosa with a shareholding of > 64%
  • The Company is highly levered with debts bearing interest of between 6-13% and the net margins is too low for my liking. Having said that, if the Company is listed and can refinance its debt at lower interest rates, it will help improve the profitability going forward
  • With all due respect to RSM, the accounts are not audited by a Big 4

Valuation

The pro-forma NAV is about S$0.66 and the listing price of $0.80 represents a price to book of around 1.2x, which in my view, is a reasonable price to buy for an established business.

Mr IPO's rating

I quite like this sector in which the Company is playing and that we can attract the Company to list here. My key concern will be the highly geared nature in which the Company is taking on debt to expand. To pay 12.75% interest rate on the notes is crazy given the low interest rate environment. I have done a quick and dirty forecast to derive the fair value (which i believe is totally off-mark so read at your own risk).


I have assumed a fair value of 15-18x PE and 6-7x EBITDA which i believe is fair for JAPFA. I am sure if the business is available at 6x EBITDA, many PE firms will be queuing up to acquire the firm. Based on the PE basis, the fair value range comes in at between 91-110c and based on the EBITDA range, the fair value comes out at between 85c to 100c. 

According to the Edge report, Marubeni is coming in as an anchor investor. The original book building range was between $0.75 to $0.87 and the Company priced it a $0.80 eventually given the current IPO sentiments.

Setting the high debts aside, i believe the Company is interesting enough for the medium term with growth initiatives coming on stream. I will give it a 2 Chilli ratings for the medium term but do watch the debt level closely and see if the Company is able to pay down its debt or refinance them at a lower cost.  

Happy Mooing. 

Comments

Anonymous said…
Sir, u got any placement from broker??

Applying public tranche?
Mr. IPO said…
Probably yes. Will decide how much to apply on tues
Cherub said…
BTW Mr IPO,
whe you get IPO from your broker, instead of ordinary application via ATMs, do you pay another fee? This fee is for assurance that you will definitely get the shares? (as compared to ATM, when oversubscribe, people will only get 1 or 2 lots...)

Also, do u post blog posts of your holdings, like some IPO u hold but u will sell after 1 year etc etc.

it would be interesting to see what stocks to sell off later.. i usually hold my IPO till later.. dunno when is good to sell

:P
Mr. IPO said…
Placement shares will incur 1% fees and you are "assured" of the allocation. ATM application is cheaper but need Lady Luck.

Don't have to share everything la. Already share the fair value range still have to show all personal holdings ah. No more privacy? :-P
Anonymous said…
Mr IPO, I am new to this. Are there conditions for you to get placement shares? How come my broker didnt offer me any placement shares? Are placement shares opened to everyone? Pls advise.
Wilson said…
Hi Mr Ipo

Thanks for the sharing, your analysis help alot of working adults who have no time to see all the page, but see the necessary financial ratios.

BTW, your excel spreadsheet, I suppose you put the IPO price at 0.88cents instead of 0.8. Must be still thinking of IREIT? hahaa

Thanks once again
Cherub said…
heh heh. thanks mr IPO! :D
Mr. IPO said…
Hi newbie, not all brokers are equal. Please read my postings on how to lay your hands on placement shares (link is at the top right corner of this blog).
Mr. IPO said…
Wilson, thanks for the eagle eye! Luckily it will not impact the "fair value" computation :)
Anonymous said…
this IPO can start apply now?
can apply online?
Mr. IPO said…
Yes. Already opened for application.
Anonymous said…
http://www.sgx.com/wps/portal/sgxweb/home/company_disclosure/ipos/ipo_prospectus

why i cannot found JAPFA Ltd. in SGX?
Anonymous said…
From the link http://www.fool.sg/2014/08/11/what-investors-need-to-know-about-japfa-limiteds-initial-public-offering/
Besides the high interest rates on its borrowings, there were a couple of other balance sheet-related concerns related to Japfa: 1) the company’s ratio of total borrowings to equity is rather high at 1.4; and 2) it has borrowings that are around 25 times its profit for 2013.

Japfa generated US$89.1 million in net cash from operations in 2013 as compared to US$27 million in 2012. However, capital expenditures in 2012 and 2013 were at US$201 million and US$212 million, respectively. This translates to the industrial farmer actually earning negative free cash flow in both years.

So is t a good buy?
Mr. IPO said…
As mentioned in my blog post, that is my concern as well. Whether it is a good buy or not really depends on whether the mgmt is able to execute its strategy and manage its cashflows properly.
Unknown said…
This comment has been removed by the author.
Unknown said…
Mr IPO, can we use DBS ATM or internet banking to apply this IPO?
Mr. IPO said…
Yes. You should be able to
Anonymous said…
Recent IPOs most if not all under water...so have to be very careful.

Historical PE at 23 and NAV 66cts...I am very concerned indeed.

To each his own...nobody knows what will happen until it is listed.
Mr. IPO said…
Yah lor. Do your own analysis. don't think this IPO is suitable for flippers.
Anonymous said…
Mr ipo applying?
Mr. IPO said…
yes i am applying :)
Anonymous said…
Broker offer u any??
bic_cherry said…
Why is profit margin so razor thin: like 1.5% of revenue as I read somewhere. Already so debt laden, if not profitable enough, can easily go bankrupt...
Mr. IPO said…
Japfa has been a very interesting exercise. Either u love it or hate it. Probably no in between. Do your own homework and make your own decisions. ^_^ anyway application has closed and let the market decide.
James said…
Will you be holding Japfa for investment?
Anonymous said…
Hi Mr ipo, is thr a reason why you are not using net profit attributable to owners to calculate eps which is the normal way to do?
Mr. IPO said…
Really? i thought my way is correct. what was your EPS figure?
Anonymous said…
2.82c (usd)if u use the profits attributable to owners.

I chanced upon your blogs recently and realised you do have some pretty gd write-ups.Amazed you can act find the time to blog so much despite seemingly hold a respectable position in the finance field. tks for sharing
Mr. IPO said…
Well, you will always have time to find time if you are passionate about something. Since I am doing the analysis for myself anyway, might as well share with a wider group. It's to keep myself on the toes. ^_^
Mr. IPO said…
Yes u are right. Should use the proft attributable to JAPFA instead. Hmmm seemed very expensive then. Having said that, I was relying more on EBITDA multiple :)
Anonymous said…
Recently saw the share drop to low 0.58. i wonder why.